HomeINNO • CNSX
add
Innocan Pharma Corp
Previous close
$10.19
Day range
$10.01 - $10.80
Year range
$7.00 - $21.00
Market cap
48.59M CAD
Avg Volume
1.02K
P/E ratio
-
Dividend yield
-
Primary exchange
CNSX
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 6.82M | -20.90% |
Operating expense | 7.41M | -0.24% |
Net income | -1.95M | -571.38% |
Net profit margin | -28.54 | -749.40% |
Earnings per share | — | — |
EBITDA | -1.21M | -434.35% |
Effective tax rate | -15.36% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 7.27M | 43.76% |
Total assets | 11.12M | 15.86% |
Total liabilities | 4.48M | 68.99% |
Total equity | 6.63M | — |
Shares outstanding | 4.50M | — |
Price to book | 11.85 | — |
Return on assets | -27.49% | — |
Return on capital | -37.50% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -1.95M | -571.38% |
Cash from operations | 22.00K | 102.19% |
Cash from investing | -4.00K | 33.33% |
Cash from financing | -3.00K | -100.35% |
Net change in cash | 15.00K | 111.36% |
Free cash flow | 779.75K | 232.25% |
About
Founded
2018
Website
Employees
8
